summary to determine whether endogenously generated angiotensin II (AH) enhances the release of norepinephrine from sympathetic axon terminals in the kidney, the concentration of norepinephrine in renal vein plasma was determined in the dog during renal nerve stimulation (12 V, 3 msec, 5 Hz, for 15 minutes) under control conditions and after administration of the angiotensin converting-enzyme inhibitor, captopril. Captopril was administered at a dose that completely inhibited the mean arterial pressure and renal blood flow effects of 0.2 Mg/kg of angiotensin I (AI). During control conditions (n = 13), nerve stimulation increased the rate of renal renin secretion (p < 0.01) and, therefore, the generation of AH. Under both control conditions and after captopril administration (n = 12), renal nerve stimulation decreased renal blood flow (p < 0.001) and increased renal vascular resistance (p < 0.001) and the renal venous concentration of prostaglandin E, (p < 0.05). There were no significant differences in the magnitude of these effects between the two groups of dogs. Similarly, the concentration of norepinephrine in renal venous plasma was increased by nerve stimulation in both control dogs and captopril-treated dogs (p < 0.001), and there was no difference in the magnitude of this effect. These results indicate that the renal hemodynamic and renal venous norepinephrine responses evoked by direct renal nerve stimulation were not influenced by the blockade of the converting enzyme with captopril. Accordingly, the data suggest that endogenously generated All does not facilitate the release of norepinephrine from axon terminals in the canine kidney. 
I N a previous study from this laboratory, it was shown that under basal conditions in the dog there is a net addition of norepinephrine by the kidney into renal venous plasma.
1 It was also shown that electrical renal nerve stimulation enhances the amount of norepinephrine overflowing into the renal vein and that increases in the frequency of stimulation induce linear increases in the concentration of norepinephrine in renal venous plasma. 1 Although the venous concentration of norepinephrine directly related to the frequency of renal nerve stimulation in each dog, there was a significant interanimal variation in the slopes of the lines defining this relation-ship. 1 This finding suggested that the amount of norepinephrine released per impulse was different in each animal.
In a series of studies, Zimmerman and coworkers 2 '' and others 4 ' 6 have shown that administration of angiotensin II (All) facilitates the overflow of norepinephrine into several vascular beds during adrenergic nerve stimulation. Renal nerve stimulation increases renin release" by the kidney and thus All generation. Furthermore, the renal release of renin in response to stimuli is proportional to the renin content in the kidney. 7 It is thus conceivable that the previously observed 1 interanimal variation in the stimulationevoked norepinephrine overflow could be due to different rates of renin release (and All generation) in response to renal nerve stimulation.
It is established that the kidney possesses angiotensin converting enzyme* and that there is intrarenal generation of All.* The concentration of All in the renal lymph is greater than that of systemic plasma." During hypotensive hemorrhage, intrarenal All is several orders of magnitude greater than plasma All." Furthermore, intrarenal All need not recirculate to exert its effects. 10 Recently, Mendelsohn 11 reported that intrarenal All can be inhibited by sodium loading or by the converting enzyme inhibitor, teprotide.
The purpose of the present study was to explore whether All endogenously generated within the kidney facilitates norepinephrine release by the renal sympathetic terminals. Accordingly, the overflow of norepinephrine into the renal vein during electrical stimulation of the renal nerves was measured under control conditions and during blockade of the generation of All by the inhibitor of the converting enzyme, captopril.
Methods

Experimental Preparation
The experiments were performed with 20 mongrel dogs of either sex weighing 22.6 ± 1.1 kg (mean ± SE). They were fed a normal chow diet that provided a sodium intake of 80-100 mEq/day. 12 Food, but not water, was withheld for 18 hours prior to the experiments. Anesthesia was induced with sodium pentobarbital (30 mg/kg i.v.) and maintained with periodic additional administration. After cannulation of the trachea, the dogs were ventilated with a positive-pressure respirator (Harvard Apparatus, Dover, Massachusetts). A catheter was placed in the femoral vein, and the dogs were given an infusion of Ringer lactate equal to 4% of body weight, followed by a sustaining infusion of 0.2 ml/kg-min" 1 for the remainder of the experiment. Through a femoral artery, a catheter was introduced into the aorta for arterial blood pressure measurement (P23Db Statham transducer, Hato Rey, Puerto Rico, and Grass polygraph recorder, Quincy, Massachusetts) and blood collections. Through a left flank incision and retroperitoneal dissection, the left renal artery was dissected and fitted with a flow probe of appropriate diameter (Carolina Medical Electronics). Care was taken not to cut or squeeze renal nerves. Renal blood flow was measured with an electromagnetic flowmeter as previously described. 18 Renal vascular resistance was calculated by dividing mean arterial pressure (mm Hg) by renal blood flow (ml/min) and is expressed in arbitrary resistance units (ru). Through the left testicular/ovarian vein, a small catheter was introduced in a retrograde manner into the left renal vein for blood collection. In all instances, aorta and renal vein blood samples were taken simultaneously. At least 1 hour elapsed after surgery before the experiments were started.
For nerve stimulation, the renal nerves were placed on a dipolar silver electrode connected to a Grass stimulator (Model S4). Square-wave impulses of 12 V and 3 msec duration and of 5Hz frequency were utilized. Stimulation was carried out for 15 minutes, and arterial and renal venous blood samples were obtained at 1,3, 5, and 15 minutes for determination of plasma renin activity and (PRA) and norepinephrine and prostaglandin Ej (PGEj) concentrations. In 13 dogs, after control hemodynamic measurements and blood collections, renal nerve stimulation was carried out during control conditions. In five of these dogs, after 1 hour of reequilibration, stimulation was repeated following administration of captopril (see below). In seven other dogs, captopril was administered 1 hour after completion of surgery, and 20 to 30 minutes later renal nerve stimulation was performed. Since the results of all quantities measured were similar in both groups of dogs that received captopril, the data were pooled for statistical evaluation. Captopril was administered as an intravenous bolus injection of 0.4 mg/kg followed by the continuous infusion of 0.4 jzg/kg.min" 1 for the remainder of the experiment. Renal nerve stimulation was carried out 20 to 30 minutes after the administration of captopril. The degree to which the dose of captopril inhibited angiotensin converting enzyme was assessed in six dogs by measuring the arterial blood pressure and renal blood flow responses to exogenous angiotensin I (AI). Figure 1 shows that mean arterial pressure increased by 56 ± 7 mm Hg (p < 0.001) and renal blood flow fell by 186 ± 45 ml/min (p < 0.01) after the intravenous administration of a 0.2 Mg/kg of AI as a bolus. Figure 1 also shows that neither mean arterial pressure nor renal blood flow were significantly changed by the same dose of AI after the administration of captopril.
Measurements
The PRA in arterial and renal venous blood was measured as previously described." Plasma norepinephrme was measured radioenzymatically as previously described.
1 ' 1J Prostaglandin Ej (PGEj) was measured by radioimmunoassay as previously described. 12 
Statistical Analysis
All values are expressed as mean ± SEM. Data were analyzed by analysis of variance or a t test.
14 Differences were termed significant if the F or t value exceeded the 5% level.
Results
The hemodynamic and hormonal data prior to renal nerve stimulation in the control dogs and in the dogs that received captopril are depicted in table 1. No significant differences could be detected in arterial hematocrit, mean arterial pressure and renal blood flow between the two groups. Similarly, arterial PRA, and arterial and renal venous concentrations of PGE, and of norepinephrine were not significantly different. Table 2 shows that in the control dogs, renal nerve stimulation significantly increased PRA in renal venous blood (p < 0.05). Arterial PRA also increased during nerve stimulation (p < 0.01), as well as the difference between renal venous and arterial renin activities (p < 0.05). The calculated rate of renal secretion of renin was enhanced by nerve stimulation (p < 0.01). Table 3 depicts the effect of renal nerve stimulation on renal blood flow, mean arterial pressure, and renal vascular resistance in the control dogs and in the dogs treated with captopril. There were no significant differences in these values prior to renal nerve stimulation. In both control and captopril-treated dogs, nerve stimulation significantly decreased renal blood flow (p < 0.001). As shown in table 3, the magnitude of the renal blood flow reduction was not significantly different between the two groups. Further, in both groups, the reduction in renal blood flow was maximal at 1 minute of stimulation and was followed by a progressive recovery towards the control value. Table 3 also shows that a small but statistically significant increase in mean arterial pressure was induced in both groups of dogs (p < 0.001). Since nerve stimulation decreased renal blood flow and increased mean arterial pressure to a similar degree, the increase in renal vascular resistance (p < 0.001) induced by nerve stimulation was not significantly different in the two groups of dogs (table 3) . Table 4 shows that nerve stimulation significantly increased renal venous PGE 2 in both groups of dogs (p < 0.05); there was no significant difference in this effect between groups. In contrast, PGEj concentration in arterial plasma was not significantly increased by nerve stimulation. The increase in the calculated rate of renal PGEj secretion* in both groups did not reach statistical significance, probably because of the variability of this calculated term. Table 5 depicts the effect of renal nerve stimulation on the concentration of norepinephrine in plasma. Nerve stimulation increased norepinephrine concentration in renal venous plasma in both control dogs and in dogs treated with captopril (p < 0.001). There was no statistically significant difference in the magnitude of this effect between groups. As did the renal blood flow effect, the increase in renal venous norepinephrine reached a maximum at 1 minute of
•Because the kidney is rich in prostaglandin degradating enzymes," uncertainties exist about the exact fate of arterial PGE, entering the kidney Thus, the exact influence of arterial PGE, concentration upon renal venous PGE, concentration is unknown stimulation and steadily declined toward control in both groups of dogs. The arterial norepinephrine concentration was slightly but significantly increased by nerve stimulation (p < 0.05); at 15 minutes, arterial norepinephrine remained elevated in the captopriltreated dogs. The difference between renal venous and arterial norepinephrine concentrations and the calculated rate of renal norepinephrine overflowf (table 5) were also significantly increased by nerve stimulation in the control and captopril treated dogs. There was no difference in the magnitude of the nerve stimulation effect between groups.
Discussion
The purpose of the present study was to determine whether All generated within the kidney facilitates the release of norepinephrine by renal axon terminals in response to nerve stimulation. It is currently not possible to determine the exact amount of norepinephrine released by sympathetic axon terminals. In the present study the concentration of norepinephrine in renal venous plasma was utilized as an index of release. Several lines of evidence, previously detailed, 1 provide support for this assumption.
Investigations by Zimmerman and coworkers 2 ' * and by other workers have shown that infusions of All fSince norepinephrine is both metabolized and secreted by the kidney," similar uncertainties exist about the exact fate of arterial norepinephrine entering the kidney as is the case with PGE, Thus, the term rate of norepinephrine overflow as used in this paper carries no implications about the exact influence of arterial norepinephrine concentration upon renal venous norepinephrine concentration 24.6 ± 5.5 17.7 ±3.6 *n = 10; tn = 12. Values are mean ± SEM. For abbreviations see table 2 enhance the vascular response to electrical nerve stimulation in the cutaneous, 2 splenic, 17 mesenteric," and renal' 1 "• " vascular beds and in the isolated celiac artery.* Angiotensin I also potentiated the vascular response to nerve stimulation, but its effect was dependent upon conversion to A l l . " Infusions of All also enhanced the overflow of norepinephrine into the venous effluent of most of these beds during direct nerve stimulation.
2 " 5 These results have promoted the hypothesis that All potentiates the vascular response to sympathetic nerve stimulation by enhancing the release of neurotransmitter from the axon terminals."
Several studies suggest, however, that the proposed All enhancement of norepinephrine release from sympathetic nerves may not be present in certain vascular beds. First, in the paper of Zimmerman et al." exogenous All infusion did not augment the overflow of norepinephrine into the renal venous blood during electrical stimulation of the renal nerves in the dog. Similar data were obtained by Herting and Suko 17 using the isolated perfused cat spleen. Second, in dogs with increased circulating renin (and presumably All) secondary to renal artery stenosis or hemorrhage, augmented norepinephrine overflow and enhanced vasoconstriction during nerve stimulation were observed in cutaneous 21 " 28 but not muscular vascular beds. 21 Third, when the renin angiotensin system was activated by hemorrhage in the dog, the vascular response to stimulation of the renal nerves was not enhanced above the response observed during the prehemorrhage control period. 24 In the present investigation, the role of endogenous All in facilitating the release of norepinephrine from renal axon terminals during direct nerve stimulation was examined by inhibiting the generation of All with captopril. Mendelsohn 11 has recently shown that systemic administration of the inhibitor of the angiotensin converting enzyme teprotide markedly decreased the concentration of intrarenal All. Although intrarenal All concentration was not determined in the present study, several lines of evidence suggest that captopril effectively prevents the generation of All in response to renal nerve stimulation. First, most of the converting enzyme in the kidney is localized in the vascular endothelium" and thus is easily accessible to captopril. Captopril is more potent than teprotide 28 and distributes rapidly through the body. 27 Finally, the dose of captopril utilized abolished the renal blood flow and blood pressure effect of angiotensin I ( fig. 1 ) and has been shown to effectively block the formation of endogenous All when the renal renin secretion was stimulated. 28 In the control dogs, electrical stimulation of the renal nerves increased renal renin secretion by the kidney (table 2) and by implication increased the formation of All. 19 In these dogs, nerve stimulation also reduced renal blood flow (table 3) and increased renal vascular resistance. Similarly, in the dogs with inhibition of the converting enzyme, renal nerve stimulation decreased renal blood flow and increased renal vascular resistance. No statistically significant difference was detected between the hemodynamic effects of nerve stimulation in the two groups of dogs. These results suggest that endogenous All does not enhance the renal vascular effects of sympathetic nerves. The data are in agreement with the previous observation that increased endogenous All had no effect on the increase in renal vascular resistance evoked by nerve stimulation."
In the control dogs, nerve stimulation increased the renal venous concentration of norepinephrine (table  5) ; renal venous norepinephrine reached a maximum at 1 minute and then progressively declined towards control values. In the dogs treated with captopril, renal nerve stimulation also increased the concentration of norepinephrine in renal venous plasma and this response was not significantly different from that observed in control dogs (table 5) . Analysis of the nerve stimulation effect on renal norepinephrine overflow in terms of the renal venous minus arterial concentration difference or the calculated rate of renal secretion also showed no significant difference between the control and the captopril-treated dogs. In the aggregate, therefore, these results suggest that the amount of neurotransmitter released by the axon terminal in response to electrical stimulation of the renal nerves in the control dogs was not different from that of the captopril-treated dogs. Since generation of All in the kidney of the captopril-treated dogs was very likely inhibited while All generation was undoubtedly increased in the control dogs, these results suggest that the level of intrarenal All does not facilitate release of norepinephrine during direct nerve stimulation in the kidney.
Since both the renal vasoconstriction and the increase in renal venous norepinephrine concentration induced by nerve stimulation were similar in the control dogs and in the captopril-treated dogs, the results also suggest that captopril does not interfere with postganglionic sympathetic function.
In the present study, renal venous PGE, was determined because exogenous PGE S has been shown to influence the overflow of norepinephrine.* 0 ' 31 In agreement with previous studies," renal nerve stimulation in the control dogs increased renal venous concentration of PGEs (table 4) . Similarly, renal venous concentration of PGE, was also increased by nerve stimulation in the captopril-treated dogs (table 4) , and no significant difference in the magnitude of this effect was found between the two groups of animals. This finding suggests that the increase of renal PGEj synthesis induced by nerve stimulation was not mediated by All.
In summary, the present study demonstrates that renal nerve stimulation induces constriction of the renal vascular bed and enhances renin secretion by the kidney as well as renal PGEj synthesis and renal overflow of norepinephrine. Blockade of the generation of All with captopril had no significant effect on the renal hemodynamic and renal PGEj synthesis effects induced by renal nerve stimulation. Similarly, captopril had no effect on the increase of norepinephrine overflow in response to nerve stimulation. The data suggest that the All generated during renal nerve stimulation does not facilitate norepinephrine release in the sympathetic axon terminals of the canine kidney and that captopril does not interfere with peripheral sympathetic function.
